Rule
25 Mar 2025
compliance, regulation, pharmaceuticals, fda, health, nonprescription drugs
💊Implications of New Nonprescription Drug Regulations for Businesses
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
Learn More
Compliance, Regulatory Changes
27 Jan 2025
regulatory compliance, health regulations, nonprescription drugs, drug application, fda
📜FDA Delays Effective Date for Nonprescription Drug Regulation
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) is delayed until March 21, 2025.
Learn More